Prevalence and factors associated with traditional herbal medicine use among patients on highly active antiretroviral therapy in Uganda

dc.contributor.authorNamuddu, Betty
dc.contributor.authorKalyango, Joan N.
dc.contributor.authorKaramagi, Charles
dc.contributor.authorMudiope, Peter
dc.contributor.authorSumba, Samwel
dc.contributor.authorKalende, Henry
dc.contributor.authorWobudeya, Eric
dc.contributor.authorKigozi, Brian K.
dc.contributor.authorWaako, Paul
dc.date.accessioned2022-02-03T19:35:31Z
dc.date.available2022-02-03T19:35:31Z
dc.date.issued2011
dc.description.abstractIn Africa, herbal medicines are often used as primary treatment for Human immunodeficiency virus (HIV) related problems. Concurrent use of traditional herbal medicines (THM) with antiretroviral drugs (ARVs) is widespread among HIV infected patients. However, the extent of THM use is not known in most settings in Sub- Saharan Africa. This study aimed at determining the prevalence and factors associated with THM use among HIV infected patients on highly active antiretroviral therapy (HAART) attending The AIDS Support Organization (TASO) in Uganda. TASO is a non-governmental organization devoted to offering HIV/AIDS care and treatment services in the population. Methods: This was a cross-sectional study carried out in two TASO treatment centres in Uganda among 401 randomly selected eligible participants. We included participants who were 18 years and above, were enrolled on HAART, and consented to participate in the study. Data was collected using an interviewer-administered semistructured questionnaire. THM use referred to someone who had ever used or was currently using herbal medicine while on highly active antiretroviral therapy (HAART) by the time of the study. Data was captured in Epi-data version 3.1 and exported to STATA version 9.0 for analysis. Results: The prevalence of THM use was 33.7%. Patients on HAART for < 4 years were more likely to use THM (OR = 5.98, 95% CI 1.13 - 31.73) as well as those who experienced HAART side effects (OR = 3.66, 95% CI: 1.15 - 11.68). Older patients (≥39 years) were less likely to use THM (OR = 0.26 95% CI: 0.08 - 0.83). Participants with HAART adherence levels > 95% were less likely to use THM (OR = 0.09, 95% CI 0.01 - 0.65). Conclusion: The prevalence of THM use among participants on HAART was high. This raises clinical and pharmacological concerns that need attention by the health care service providers.en_US
dc.identifier.citationNamuddu et al.: Prevalence and factors associated with traditional herbal medicine use among patients on highly active antiretroviral therapy in Uganda. BMC Public Health 2011 11:855. doi:10.1186/1471-2458-11-855en_US
dc.identifier.other10.1186/1471-2458-11-855
dc.identifier.urihttps://nru.uncst.go.ug/xmlui/handle/123456789/1847
dc.language.isoenen_US
dc.publisherBMC Public Healthen_US
dc.subjectPrevalenceen_US
dc.subjectTraditional herbal medicineen_US
dc.subjectPatientsen_US
dc.subjectAntiretroviral therapyen_US
dc.subjectUgandaen_US
dc.titlePrevalence and factors associated with traditional herbal medicine use among patients on highly active antiretroviral therapy in Ugandaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Prevalence and factors associated with traditional.pdf
Size:
307.21 KB
Format:
Adobe Portable Document Format
Description:
Article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: